Profile
Dr. Jan Brinkman, MD PhD, is on the Board of Directors at Boston Therapeutics, Inc.
He received his MBA from INSEAD, a doctorate degree from the University of Florence, and a doctorate degree from Erasmus University Rotterdam.
Former positions of Jan Brinkman
| Companies | Position | End |
|---|---|---|
| NANOMIX CORPORATION | Director/Board Member | 2016-02-22 |
Training of Jan Brinkman
| Erasmus University Rotterdam | Doctorate Degree |
| INSEAD | Masters Business Admin |
| University of Florence | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
- Stock Market
- Insiders
- Jan Brinkman
